Oxidative Stress Peripheral Parameters in Graves' Disease: the Effect of Methimazole Treatment in Patients with and Without Infiltrative Ophthalmopathy
Overview
Affiliations
Objectives: The study was designed to estimate the influence of hyperthyroidism and antithyroid treatment on oxidative stress peripheral parameters in Graves' disease patients with and without infiltrative ophthalmopathy.
Design And Methods: Free radical generation and scavenging plasma indices were determined in 47 patients with hyperthyroidism due to Graves' disease (22 with and 25 without infiltrative ophthalmopathy), as well as in 24 healthy volunteers after euthyroidism achievement with methimazole.
Results: In the hyperthyroid patients, hydrogen peroxide, lipid hydroperoxides, thiobarbituric acid-reacting substances, ceruloplasmin, superoxide dismutase, and catalase were increased. Glutathione peroxidase and glutathione reductase, however, were reduced. Methimazole treatment resulted in all markers being normalized in the patients without infiltrative ophthalmopathy, yet oxidative stress was still present in the ophthalmopathy group.
Conclusion: We suggest that apart from the thyroid metabolic status influence, it is orbital inflammation that triggers changes in blood extracellular indices of reactive oxygen species metabolism.
The relationship between cholesterol levels and thyroid eye disease.
Cardo C, Dos Santos R, Bernardo Santos R, Pinotti Pedro Miklos A, Barbosa Jaconis S, Romaldini J Eur Thyroid J. 2025; 14(1).
PMID: 39819487 PMC: 11825156. DOI: 10.1530/ETJ-24-0133.
Thyroid-associated ophthalmopathy: the role of oxidative stress.
Ma C, Li H, Lu S, Li X Front Endocrinol (Lausanne). 2024; 15:1400869.
PMID: 39055057 PMC: 11269105. DOI: 10.3389/fendo.2024.1400869.
Chiu H, Wu S, Tsai C Int J Mol Sci. 2024; 25(6).
PMID: 38542262 PMC: 10970309. DOI: 10.3390/ijms25063288.
Ye Z, Wu H, Chen X, Xie R, Zhang D, Sun H Transl Pediatr. 2024; 13(1):38-51.
PMID: 38323179 PMC: 10839278. DOI: 10.21037/tp-23-370.
The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves' Ophthalmopathy.
Hou T, Wu S, Kau H, Tsai C Biomedicines. 2021; 9(12).
PMID: 34944687 PMC: 8698567. DOI: 10.3390/biomedicines9121871.